Health BETA
Health BETA provides genomic digital therapeutics focused on personalized health condition monitoring through genetic tests and lifestyle tracking. Their AI-based IoT system quantifies the benefits of lifestyle changes, offering solutions for cardiologists to prevent secondary heart attacks by predicting coronary artery disease (CAD) risks using genome information and integrating lifestyle factors like physical activity and diet. They also engage in Gene-Lifestyle Interaction (GxE) research, inviting collaborations to advance predictive health models. Key offerings include CAD risk assessment using genetic variants and lifestyle data, and arrhythmia detection via wearable biosensors. The company's AI model is trained on a dataset of 3,200 CAD patients, primarily of Asian ethnicities.
Health BETA
Health BETA provides genomic digital therapeutics focused on personalized health condition monitoring through genetic tests and lifestyle tracking. Their AI-based IoT system quantifies the benefits of lifestyle changes, offering solutions for cardiologists to prevent secondary heart attacks by predicting coronary artery disease (CAD) risks using genome information and integrating lifestyle factors like physical activity and diet. They also engage in Gene-Lifestyle Interaction (GxE) research, inviting collaborations to advance predictive health models. Key offerings include CAD risk assessment using genetic variants and lifestyle data, and arrhythmia detection via wearable biosensors. The company's AI model is trained on a dataset of 3,200 CAD patients, primarily of Asian ethnicities.